Prophylaxis of Deep Vein Thrombosis After Total Knee Arthroplasty

  • Geoffrey H. Westrich
  • Steven B. Haas


Patients who undergo elective total knee replacement are at a high risk for deep venous thrombosis, which can lead to potentially fatal pulmonary embolism. The incidence of deep vein thrombosis after total knee replacement has been reported to be between 50 and 88% (1, 2, 3). While the majority of these thrombi occur in the calf veins and resolve without symptoms, up to 24% may propagate to the proximal veins (1). Approximately 3-10% of patient will develop proximal thrombi in the week following total knee replacement.


Total Knee Arthroplasty Deep Vein Thrombosis Deep Venous Thrombosis Total Knee Replacement Thromboembolic Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKenna R, Bachmann F, Kullshal SP, Galante JO. Thromboembolic disease in patients undergoing total knee replacement. J Bone Joint Surg 1976;58A(7):928–32.Google Scholar
  2. 2.
    Lotke PA, Ecker ML, Alavi A, Berkowitz H. Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg 1984;66A(2): 202–8.Google Scholar
  3. 3.
    Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep vein thrombosis following total knee replacement. J Bone Joint Surg 1984;66A(2):194–201.Google Scholar
  4. 4.
    Grady-Benson JC, Oishi CS, Hannson PB, Colwell CW Jr, Otis SM and Walker RJ. Postoperative surveillance for deep venous thrombosis with duplex ultrasound after total knee arthroplasty. J Bone Joint Surg. 1994;76-A, (11):1649–1657.PubMedGoogle Scholar
  5. 5.
    Haas SB, Insall JM, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential compression boots compared with aspirin prophylaxis of deep vein thrombosis after total knee arthroplasty. J Bone Joint Surg 1990;72A(¨ª):2731.Google Scholar
  6. 6.
    Lotke PA, Wong RY, Ecker ML. Asymptomatic pulmonary embolism after total knee replacement. Orthop Trans 1986;10(3):490.Google Scholar
  7. 7.
    Patterson BM, Marchand R, Ranawat C. Complications of heparin therapy after total joint arthroplasty. J Bone Joint Surg 1989;71A(8):1130–4.Google Scholar
  8. 8.
    Barritt DW, Jordan SC, Brist MB. Anticoagulant drugs in the treatment of pulmonary embolism: A controlled trial. Lancet 1960;18:1309–12.CrossRefGoogle Scholar
  9. 9.
    Kraritz E, Karino T. Pathophysiology of deep vein thrombosis. In: Leclerc JR. Venous thromboembolic disorders. Philadelphia:Lea and Febiger, 1991:54–64.Google Scholar
  10. 10.
    Virchow R. Neuer fall von todlicher emboli der kungerarteries. Arch Path Anat 1856;10:225.Google Scholar
  11. 11.
    Garino J, Lotke P, Kitziger K, Steinberg M. Deep Venous Thrombosis after Total Joint Arthroplasty: The Role of Compression Ultrasonography and the Importance of Experience of the Technician. J Bone Joint Surg 1996;78A:1359–65.Google Scholar
  12. 12.
    Hirsh J, Salzman EW, Harker L, et al. Aspirin and other platelet active drugs: Relationship among dose, effective-ness and side effects. Chest 1989;95(Suppl 2):12s-16s.Google Scholar
  13. 13.
    Mizel, MS, Temple, HT, Michelson, JD, Alavarez, et al. Clinically apparent thromboembolism following foot and ankle surgery. In: Foot and Ankle Annual Meeting, June 30, 1996.Google Scholar
  14. 14.
    Lotke PA. Aspirin prophylaxis for thromboembolic disease. In Instructional Course Lectures, The American Academy of Orthopedic Surgeons. Vol. 44, St. Louis, C. V. Mosby, 1995.Google Scholar
  15. 15.
    Tarnay TJ, Rohr PR, Davidson AG, Stevenson MM, Byars EF, Hopkins GR. Pneumatic calf compression, fibrinolysis, and the prevention of deep venous thrombosis. Surgery 1980;88:489–96.PubMedGoogle Scholar
  16. 16.
    Wilson NV, Das SK, Kakkar VV, Maurice HD Smibert JG, Thomas EM and Nixon JE, Thrombo-embolic prophylaxis in total knee replacement. Evaluation of the A-V impulse system. J Bone Joint Surg.99,1992; 74BGoogle Scholar
  17. 17.
    Knight MTN, Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976;2:1265–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Lynch JA, Baker PL, Polly RE, et al. Mechanical measures in the propylaxis of post-operative thromboembolism in total knee arthroplasty. Clin Orthop 1990;260:24–9.PubMedGoogle Scholar
  19. 19.
    Hodge WA. Warfarin and sequential calf compression in the prevention of deep vein thrombi following total knee replacement. Presented at the Knee Society, Las Vegas, February, 1989.Google Scholar
  20. 20.
    Kaempffe FA, Lifeso RM, Meinding C. Intermittent pneumatic compression versus coumadin: Prevention of deep vein thrombosis in lower-extremity total joint arthroplasty. Clin Orthop 1991;269:89–79.PubMedGoogle Scholar
  21. 21.
    Graor RA, Davis AW, Borden LS, Young J. Comparative evaluation of deep vein thrombosis prophylaxis in total joint replacement patients. Presented at AAOS, Las Vegas, February, 1989.Google Scholar
  22. 22.
    Hood RW, Flawn LB, Insall JN. The use of pulsatile corn-pression stockings in total knee replacement for prevention of venous thromboembolism: A prospective study. Presented at the ORS, New Orleans, January, 1982.Google Scholar
  23. 23.
    Hull R, Delmore Ti, Hirsh J, et al. Effectiveness of intermittent pulsatile elastic stockings for the prevention ofcalf and thigh vein thrombosis in patients undergoing elective knee surgery. Thromb Resear 1979;16:37–45.CrossRefGoogle Scholar
  24. 24.
    Westrich GH, Sculco TP. Prophylaxis against Deep Vein Thrombosis after Total Knee Arthroplasty. Pneumatic Plantar Compression and Aspirin Compared to Aspirin Alone. J Bone Joint Surg 1996;78A(6):826Google Scholar
  25. 25.
    Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982;307:1676–81PubMedCrossRefGoogle Scholar
  26. 26.
    Greenfield LJ, Michna B. Twelve year clinical experience with the Greenfield vena caval filter. Surgery 1988;104:706–12.PubMedGoogle Scholar
  27. Emerson RH, Cross R, Head WC. Prophylaxtic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty. J Arthroplasty 1991;6:129–35Google Scholar
  28. 28.
    Donaldson GA, Williams C, Scannell JG, et al: A reappraisal of the application of the Trendelenburg operation to massive fatal embolism: Report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass. N Engl J Med 1963: 268:171–174.PubMedCrossRefGoogle Scholar
  29. 29.
    Anderson FA. Wheeler HB: Venous thromboembolism: Risk factors and prophylaxis. Clin Chest Med 1995; 23,52–51.Google Scholar
  30. 30.
    Anderson FA Jr, Wheeler HB, Goldberg RJ, et al: A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: The Worcester DVT Study. Arch Intern Med 1991; 151:933–938.PubMedCrossRefGoogle Scholar
  31. 31.
    Rahr HB, Sorensen IV: Venous thromboembolism and cancer. Blood Coagul Fibrinolysis 1992:3:451–460.PubMedGoogle Scholar
  32. 32.
    Geerts W, Code KI, Jay RM, et al: A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601–1606.PubMedCrossRefGoogle Scholar
  33. 33.
    Clagett GP, Reisch JS: Prevention of venous thrombosis in general surgical patients. Results of meta-analysis. Ann Surg 1988; 208–227.Google Scholar
  34. 34.
    Paiement GD, Bell D, Wessinger SJ, et al: New advances in the prevention, diagnosis, and cost effectiveness of venous thromboembolic disease in patients with total hip replacement. In: The Hip, Proceedings of the Fourteenth Open Scientific Meeting of the Hip Society. St. Louis, CV Mosby, 1987, pp. 94–119.Google Scholar
  35. 35.
    Sevitt S, Gallagher NG: Prevention of venous thrombosis and pulmonary embolism in injury patients: A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femurs. Lancet 1959;ii:981–989.Google Scholar
  36. 36.
    Clagett GP, Anderson FA Jr, Levine MN, et al: Prevention of venous thromboembolism. Chest I992;102:391-S407S.CrossRefGoogle Scholar
  37. 37.
    Green D, Lee Y. Ito VY, et al: Fixed-vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury. JAMA 1988; 260:1255–1258.PubMedCrossRefGoogle Scholar
  38. 38.
    Warlow C, Terry G, Kenmure ACF, et al: A double-blind trial of low-dose subcutaneous heparin in the prevention of deep vein thrombosis after myocardial infarction. Lancet 1973;ii:934–937.CrossRefGoogle Scholar
  39. 39.
    Gibbs NM: Venous thrombosis of the lower limbs with particular reference to bedrest. B J Surg 1957:45:209–236.CrossRefGoogle Scholar
  40. 40.
    Nicolaides AN, Irving D: Clinical factors and the risk of deep venous thrombosis, in Nicolaides AN (ed): Thromboemoblism Etiology, Advances in Prevention and Management. Baltimore, University Park Press, 1975, pp 193204.Google Scholar
  41. 41.
    Carter C, Gent M: The epidemiology of venous thrombosis, in Coleman RW, Hirsh J, Marder VJ, et al (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, TB Lippincott, 1987, pp 805–819.Google Scholar
  42. 42.
    Lundgren R, Sundin T, Colleen S, et al: Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. Scand J Ural Nephrol 1986;20:101105.Google Scholar
  43. 43.
    Devor M, Barrett-Connor E, Renvall M, et al: Estrogen replacement therapy and the risk of venous thrombosis, Am J Med 1992;92:275–282.PubMedCrossRefGoogle Scholar
  44. 44.
    Stewart, WP, Youngswick, FD: Deep vein thrombosis: Diagnosis, treatment, and prevention. J. Foot Surg. 1981: 20:232–238.PubMedGoogle Scholar
  45. 45.
    Agnelli G: Anticoagulation in the prevention and treatment of pulmonary embolism. Chest 1995; 107:39S–44S.PubMedCrossRefGoogle Scholar
  46. 46.
    Jorgensen LN, Willie-Jorgensen P, Hauch O: Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993;80:689–704.PubMedCrossRefGoogle Scholar
  47. 47.
    Carter CA, Skoutakis VA, Spiro TE, et al: Enoxaparin: The low-molecular-weight heparin for prevention of postoperative thromboembolic complications. Ann Pharmacother 1993; 27:1223–1230.PubMedGoogle Scholar
  48. 48.
    Noble S, Peters DH, Goa KL: Enoxaparin: A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease. Drugs 1995;49:388–410PubMedCrossRefGoogle Scholar
  49. 49.
    Frampton JE, Faulds D: Pamaparin: A review of its pharmacology, and clinical application in the prevention and treatment of thromboembolic and other vascular disorders. Drugs 1994;47:652–676PubMedCrossRefGoogle Scholar
  50. 50.
    Collignon F, Frydman A, Caplain H, et al: Comparison of the pharmacokinetic profiles of three low molecular mass heparins- Dalteparin, enoxaparin and nadroparin- Administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism). Thromb Haemost 1995;73:630–640.PubMedGoogle Scholar
  51. 51.
    Friedel HA, Balfour JA: Tinzaparin: A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders. Drugs 1994.;48:638–660.PubMedCrossRefGoogle Scholar
  52. 52.
    Menzin F, Colditz GA, Re-an MM, et al: Cost-effectiveness of enoxaparin vs low-dose warfarin in the prevention of deep-vein thrombosis after total hip replacement surgery. Arch Intern Med 1995;155:757–764.PubMedCrossRefGoogle Scholar
  53. 53.
    Warkentin TE, Levine MN, Hirsh J, et al: Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995;273:1032–1038.Google Scholar
  54. 54.
    Bern MM, Lokich JJ, Wallach SR, et al: Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112:423–428.PubMedGoogle Scholar
  55. 55.
    Wells PS, Lensin AWA, Hirsh J: Graduated compression stockings in the prevention of postoperative venous thromboembolism. Arch Intern Med 1994; 154:67–71.PubMedCrossRefGoogle Scholar
  56. 56.
    Knight MTN, Dawson R: Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976;ii: 1265–1267.CrossRefGoogle Scholar
  57. 57.
    Nicolaides AN, Fernandes JF, Pollock AV: Intermittent sequential pneumatic compression of the legs in the prevention of venous stasis and postoperative deep venous thrombosis. Surgery 1980;87:69–76.PubMedGoogle Scholar
  58. 58.
    Fordyce MJF, Ling RSM: A venous foot pump reduces thrombosis after total hip replacement. J Bone Joint Surg 1992;74-B:45–49.Google Scholar
  59. 59.
    Ramos R, Salem BI, De Pawlikowski MP: The efficacy of pneumatic compression stockings in the prevention of pulmonary embolism after cardiac surgery. Chest 1996; 109:82–85.PubMedCrossRefGoogle Scholar
  60. 60.
    Keith SL, McLaughlin DJ, Anderson FA, et al: Do graduated compression stocking and pneumatic boots have anadditive effect on the peak velocity of venous blood flow? Arch Surg 1992;127:727–730.Google Scholar
  61. 61.
    Fisher CG, Blachut PA, Salvian, et al: Effectiveness of pneumatic leg compression devices for the prevention of thromboembolic disease in orthopaedic trauma patients: A prospective, randomized study of compression alone versus no prophylaxis. J Orthop Trauma 1995; 1–7.Google Scholar
  62. 62.
    Jacobs DG, Piotrowski JJ, Hoppensteadt, et al: Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: Preliminary results. J Trauma 1996; 4:710–717.CrossRefGoogle Scholar
  63. 63.
    Mohan CR, Hoballah JJ, Shari WJ, et al: Comparative efficacy and complications of vena caval filters. J Vasc Surg 1995;21:235–246.PubMedCrossRefGoogle Scholar
  64. 64.
    Alexander JJ, Yuhas JP, Piotrowski JJ: Is the increasing use of prophylactic percutaneous IVC filters justified? Am J Surg 1994; 168:102–106.PubMedCrossRefGoogle Scholar
  65. 65.
    Clagett GP, Anderson FA Jr, Heit J, et al: Prevention of venous thromboembolism. Chest 1995: 108(Suppl):312S–334S.PubMedCrossRefGoogle Scholar
  66. 66.
    Hirsh DR, Ingenito EP, Goldhaber SZ: Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274:335–337.CrossRefGoogle Scholar
  67. 67.
    Keane MG, Ingenito FP, Goldhaber SZ: Utilization of venous thromboembolism prophylaxisin the medical intensive care unit. Chest 1994;106:13–14.Google Scholar
  68. 68.
    Cade JF: High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448–450.PubMedCrossRefGoogle Scholar
  69. 69.
    Halkin H, Goldberg J, Modan M, et al: Reduction of mortality in general medical inpatients by low-dose heparin prophylaxis. Ann Intern Med 1982;96:561–565.PubMedGoogle Scholar
  70. 70.
    Gardlund B: Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. Lancet 1996;347:13571361.Google Scholar
  71. 71.
    Keaton C, Hirsh J: Starting prophylaxis for venous thromboembolism postoperatively. Arch Intern Med 1995; 155:366–372.CrossRefGoogle Scholar
  72. 72.
    Ziomek S, Read RC, Tobler HG, et al: Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 1993;56:223–227.PubMedCrossRefGoogle Scholar
  73. 73.
    Nurmohamed NIT. Verhaeghe R, Haas S, et at: A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery, Am J Surg 1995; 169:567–571.PubMedCrossRefGoogle Scholar
  74. 74.
    Kakkar VV, Cohen AT. Edmonson RA, et al: Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 1993;341:259–265.Google Scholar
  75. 75.
    Caprini JA, Arcelus JI, Hoffman K, et al: Prevention of venous thromboembolism in North America: Results of a survey among general surgeons. J Vasc Surg 1994:20:751758.Google Scholar
  76. 76.
    Janku GV, Paiement GD, Green HD: Prevention of venous thromboembolism in orthopaedics in the United States. Cln Orthop 1996;325:313–321.CrossRefGoogle Scholar
  77. 77.
    Bergqvist D, Benoni G, Bjorgell O, et al: Low-molecularweight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996;335:696–700.PubMedCrossRefGoogle Scholar
  78. 78.
    Warwick D, Williams MH, Bannister GC: Death and thromboembolic disease after total hip replacement. J Bone Joint Surg 1995;77-B:6–10.Google Scholar
  79. 79.
    Pellegrini DV, Laghans MJ, Totterman S. et al: Embolic complications of calf thrombosis following total hip arthroplasty. J Arthroplasty 1993;8:449–457.PubMedCrossRefGoogle Scholar
  80. 80.
    Imperiale TF, Speroff T: A meta-analysis of methods to prevent venous thromboembolism following total hip replacement. JAMA 1994;271:1780–1785.PubMedCrossRefGoogle Scholar
  81. 81.
    Leclerc JR, Geerts WH, Desjardins L, et al: Prevention of deep vein thrombosis after major knee surgery-A randomized, double-blind trial comparing a low molecular weight heparin fragment (enoxaparin) to placebo. Thromb Haeinost 1992;67:417–423.Google Scholar
  82. 82.
    Fauno P, Suomalainen AO, Rehnberg V, et al: Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg 1994;12:18141818.Google Scholar
  83. 83.
    Frim DM, Barker FG, Poletti CE, et al: Postoperative low-dose heparin decreases thromboembolic complications in neurosurgical patients. Neurosurgery 1992;30:830–833.PubMedCrossRefGoogle Scholar
  84. 84.
    Green D, Chen D, Chmiel JS et al: Prevention of thromboembolism in spinal cord injury: Role of low molecular weight heparin. Arch Phys Med Rehabil 1994:75:290292.Google Scholar
  85. 85.
    Hamilton MD, Hull RD, Pineo GF: Prophylaxis of venous thromboembolism in brain tumor patients. J Neurooncol 1994:22:111–126.PubMedCrossRefGoogle Scholar
  86. 86.
    Britt LD. Zolfaghari D, Kennedy E, et al: Incidence and prophylaxis of deep vein thrombosis in a high risk trauma population. Am J Surg 1996; 172:13–14.Google Scholar
  87. 87.
    Knudson MM, Lewis FR, Clinton A. et al: Prevention of venous thromboembolism in trauma patients. J Trauma 1994;37:480–487.PubMedCrossRefGoogle Scholar
  88. 88.
    Upchurch GR, Demling, RH, Davies J. et al: Efficacy of subcutaneous heparin in prevention of venous thromboembolic events in trauma patients. Am Surgeon 1995;61:749–755.PubMedGoogle Scholar
  89. 89.
    Knudson MM, Collins JA, Goodman SB, et al: Thromboembolism following multiple trauma. J Trauma 1992:32:2–11.PubMedCrossRefGoogle Scholar
  90. 90.
    Geerts WH, Jay RM, Code KI, et al: A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701–707.PubMedCrossRefGoogle Scholar
  91. 91.
    Eriksson BI, Ekman S, Kalebo P, et al: Prevention of deep-vein thrombosis after total hip replacement: Direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996;347:635–639.PubMedCrossRefGoogle Scholar
  92. 92.
    Cole CW, Shea B, Bormanis J: Ancrod as prophylaxis or treatment from thromboembolism in patients with multiple trauma. Can J Surg 1995;38:249–254.PubMedGoogle Scholar
  93. 93.
    Flinn NVR, Sandaraer GP, Silva MB, et al: Prospective surveillance for perioperative venous thrombosis. Arch Surg 1996; 131:472–480.PubMedCrossRefGoogle Scholar
  94. 94.
    Grady-Benson JC, Oishi CS, Hanson PB, et al: Postoperative surveillance for deep venous thrombosis with duplex ultrasonography after total knee arthroplasty, J Bone Joint Surg 1994:76-A:1649–1657.PubMedGoogle Scholar
  95. 95.
    Wells PS, Lensina AW, Davidson BL, et al: Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery.A meta-analysis. Ann Intent Med 1995; 122:47–53.Google Scholar
  96. 96.
    Pederson O.M, Aslaksen A, Vik-Mo H, et al: Compression ultrasonography in hospitalized patients with suspected deep venous thrombosis. Arch Intern Med 1991; 151:2217–2220.CrossRefGoogle Scholar
  97. 97.
    Howell R, Fidler J, Letsky E, et al: The risks of antenatal subcutaneous heparin prophylaxis: A controlled Trial. Br J Obstet Gynaecol 1983;90:1124–1128.PubMedCrossRefGoogle Scholar
  98. 98.
    Barbour LA, Pickard J: Controversies in thromboembolic disease during pregnancy: A critical review. Obstet Gynaecol 1995;86:621–633.Google Scholar
  99. 99.
    Westrich GH, Schneider R, Ghelman B, et al. The Incidence Of Deep Venous Thrombosis With Color DopplerImaging Compared To Ascending Venography In Total Joint Arthroplasty: A Prospective Study, Contemporary surgery, Vol. 51 (4), 1997:225–234.Google Scholar
  100. 100.
    Haas SB, Tribus CB, Insall JN, Becker MW, Windsor RE. The significance of calf thrombi after total knee arthroplasty. J Bone Joint Surg 1992;74B:799–802.Google Scholar
  101. 101.
    Lieberman JR, Huo M, Hanaway J, Salvati E, Sculco T, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J. Bone Joint Surg.1994; 76-A: 341–348.PubMedGoogle Scholar
  102. 102.
    Haas S, Mosca P, Peterson, M, Westrich G. Meta Analysis of Thromboembolic Prophylaxis in Total KneeArthroplasty. Presented at AAHKS Meeting, Dallas, TX, 1996.Google Scholar
  103. 103.
    Colwell C, Spiro T, Trowbridge A, Stephens, JW, Gardiner, GA, Ritter, MA. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis after elective knee arthroplasty. Clin Orthop 1995; 321:19–27.PubMedGoogle Scholar
  104. 104.
    Westrich GH, Allen ML, Tarantino SJ, Derkowska I, Schneider R, Ghelman B, Ranawat C, Sculco TP: Ultrasound screening for deep venous thrombosis in total knee arthroplasty: Our two year reassessment of the learning curve, (Clin Orthop, Under Review).Google Scholar

Copyright information

© Springer-Verlag Wien 2001

Authors and Affiliations

  • Geoffrey H. Westrich
    • 1
  • Steven B. Haas
    • 1
  1. 1.The Hospital for Special SurgeryNew York

Personalised recommendations